Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 18, 2022

Total Value: $283M (100.0% shares, 0.0% debt)

Holdings (21)

BBIO BridgeBio Pharma Inc. (BBIO) 35.7%

Value $101M Shares 6,068,125 Est. Cost $40.43 Unrealized +4.7%

GLUE Monte Rosa Therapeutics Inc. (GLUE) 10.6%

Value $30.07M Shares 1,472,331 Est. Cost $20.37 Unrealized +2.8%

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 7.9%

Value $22.44M Shares 1,025,000 Est. Cost $10.24 Unrealized +80.4%

NUVB Nuvation Bio Inc. (NUVB) 7.6%

Value $21.6M Shares 2,541,009 Est. Cost $11.18 Unrealized -17.8%

— Elevation Oncology Inc. (ELEV) 6.0%

Value $17.07M Shares 2,834,910 Est. Cost $13.57 Unrealized —

HRMY Harmony Biosciences Holdings Inc. (HRMY) 5.3%

Value $15.15M Shares 355,415 Est. Cost $36.46 Unrealized +9.3%

— Talaris Therapeutics Inc. (TALS) 3.7%

Value $10.44M Shares 682,923 Est. Cost $14.69 Unrealized —

ACRS Aclaris Theraputics Inc. (ACRS) 3.3%

Value $9.225M Shares 634,455 Est. Cost $10.31 Unrealized +47.0%

— Verona Pharma plc (VRNA) 3.2%

Value $8.954M Shares 1,332,485 Est. Cost $7.38 Unrealized —

— Aeglea Biotherapeutics Inc. (AGLE) 2.8%

Value $8.033M Shares 1,691,151 Est. Cost $8.00 Unrealized —

— Reneo Pharmaceuticals Inc. (RPHM) 2.7%

Value $7.576M Shares 886,075 Est. Cost $9.33 Unrealized —

— Poseida Therapeutics Inc. (PSTX) 2.5%

Value $7.105M Shares 1,043,267 Est. Cost $8.87 Unrealized —

BMEA Biomea Fusion Inc. (BMEA) 2.1%

Value $5.951M Shares 798,757 Est. Cost $17.65 Unrealized -40.1%

— Spruce Biosciences, Inc. (SPRB) 1.9%

Value $5.377M Shares 1,205,511 Est. Cost $24.31 Unrealized —

— AVROBIO, Inc. (AVRO) 1.4%

Value $3.888M Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 1.1%

Value $2.986M Shares 3,142,857 Est. Cost $4.35 Unrealized —

— ObsEva SA (OBSV) 1.0%

Value $2.759M Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Zosano Pharma Corporation (ZSAN) 0.5%

Value $1.278M Shares 2,718,226 Est. Cost $2.15 Unrealized —

— Atreca Inc. (BCEL) 0.4%

Value $1.175M Shares 387,653 Est. Cost $18.84 Unrealized —

— Viracta Therapeutics Inc. (VIRX) 0.4%

Value $1.053M Shares 288,571 Est. Cost $11.34 Unrealized —

— Nabriva Therapeutics plc (NBRV) 0.0%

Value $114K Shares 191,028 Est. Cost $1.66 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$101M	35.7%	$40.43	+4.7%	COM	10806X102
GLUE	Monte Rosa Therapeutics Inc. (GLUE)	1,472,331	$30.07M	10.6%	$20.37	+2.8%	COM	61225M102
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$22.44M	7.9%	$10.24	+80.4%	COM	87164F105
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$21.6M	7.6%	$11.18	-17.8%	COM CL A	67080N101
—	Elevation Oncology Inc. (ELEV)	2,834,910	$17.07M	6.0%	$13.57	—	COM	28623U101
HRMY	Harmony Biosciences Holdings Inc. (HRMY)	355,415	$15.15M	5.3%	$36.46	+9.3%	COM	413197104
—	Talaris Therapeutics Inc. (TALS)	682,923	$10.44M	3.7%	$14.69	—	COM	87410C104
ACRS	Aclaris Theraputics Inc. (ACRS)	634,455	$9.225M	3.3%	$10.31	+47.0%	COM	00461U105
—	Verona Pharma plc (VRNA)	1,332,485	$8.954M	3.2%	$7.38	—	SPONSORED ADS	925050106
—	Aeglea Biotherapeutics Inc. (AGLE)	1,691,151	$8.033M	2.8%	$8.00	—	COM	00773J103
—	Reneo Pharmaceuticals Inc. (RPHM)	886,075	$7.576M	2.7%	$9.33	—	COM	75974E103
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$7.105M	2.5%	$8.87	—	COM	73730P108
BMEA	Biomea Fusion Inc. (BMEA)	798,757	$5.951M	2.1%	$17.65	-40.1%	COM	09077A106
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$5.377M	1.9%	$24.31	—	COM	85209E109
—	AVROBIO, Inc. (AVRO)	1,009,779	$3.888M	1.4%	$16.72	—	COM	05455M100
—	Marker Therapeutics, Inc. (MRKR)	3,142,857	$2.986M	1.1%	$4.35	—	COM	57055L107
—	ObsEva SA (OBSV)	1,386,338	$2.759M	1.0%	$12.66	—	COM	H5861P103
—	Zosano Pharma Corporation (ZSAN)	2,718,226	$1.278M	0.5%	$2.15	—	COM NEW	98979H202
—	Atreca Inc. (BCEL)	387,653	$1.175M	0.4%	$18.84	—	CL A COM	04965G109
—	Viracta Therapeutics Inc. (VIRX)	288,571	$1.053M	0.4%	$11.34	—	COM	92765F108
—	Nabriva Therapeutics plc (NBRV)	191,028	$114K	0.0%	$1.66	—	SHS	G63637113